Pcsa stock
Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... PCSA. Trailing total returns as ...You can find your newly purchased PCSA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets. Processa Pharmaceuticals Stock Earnings The value each PCSA share was expected to gain vs. the value that each PCSA share actually gained.
Did you know?
A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.PCSA is unchanged $0.00 from the previous closing price of $0.55 on volume of 537,604 shares. Over the past year the S&P 500 has risen 17.03% while PCSA is lower by -70.59%. PCSA lost -$1.44 per share the over the last 12 months. Click Here to get the full Stock Report for Processa Pharmaceuticals Inc stock.May 16, 2024 1:36 AM ET Adial Pharmaceuticals, Inc. (ADIL) Stock By: Meghavi Singh, SA News Editor. Adial Pharmaceuticals press release ( NASDAQ: ADIL ): Q1 net …Processa Pharmaceuticals Price Performance. PCSA opened at $2.18 on Monday. The firm has a market capitalization of $6.23 million, a PE ratio of -0.44 and a …
The consensus among . 1 Wall Street analyst covering (NASDAQ: PCSA) stock is to Buy PCSA stock.Out of . 1 analyst, 0 (0%) are recommending PCSA as a Strong Buy, 1 (100%) are recommending PCSA as a Buy, 0 (0%) are recommending PCSA as a Hold, 0 (0%) are recommending PCSA as a Sell, and 0 (0%) are recommending PCSA as a Strong Sell.If …Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.With Processa Pharmaceuticals stock trading at $2.22 per share, the total value of Processa Pharmaceuticals stock (market capitalization) is $6.34M. Processa Pharmaceuticals stock was originally listed at a price of $2,058.00 in Nov 21, 2013. If you had invested in Processa Pharmaceuticals stock at $2,058.00, your return over the last … As of 1:30 PM EDT. Market Open. HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical ...
Processa Pharmaceuticals Inc PCSA shares are trading higher by 36.9% to $0.28 during Friday’s session after the company announced plans to expand the development of Next Generation Capecitabine (“NGC-Cap”) into the treatment of advanced or metastatic breast cancer.. What Else? Following discussions with the FDA, the …Get the latest stock price, quote, news and history of PCSA, a biotechnology company developing drugs for neurodegenerative diseases. See key data, market cap, data … ….
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Pcsa stock. Possible cause: Not clear pcsa stock.
The current Processa Pharmaceuticals [ PCSA] share price is $2.35. The Score for PCSA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. PCSA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.Processa Pharmaceuticals Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology …Stock Analysis provides real-time and historical data, news, charts and analysis for PCSA, a clinical-stage pharmaceutical company focused on developing the next generation of 5 …
PROCESSA PHARMACEUTICALS INC (PCSA) US74275C3043 - Common Stock . 1.58 +0.02 (+1.28%) After market: 1.45 -0.13 (-8.23%) Profile . Stock Chart . Technical Analysis . Fundamental Analysis . Analyst Ratings . Estimates . Financials . Ownership . News . Full profile views are only available for registered users, you can see which data is available …Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) is a clinical-stage pharmaceutical company focusing on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for cancer patients. CEO George Ng recently issued a letter to shareholders, emphasizing the company's pivot to focus on oncology drug … Complete Processa Pharmaceuticals Inc. stock information by Barron's. View real-time PCSA stock price and news, along with industry-best analysis.
pixel watch 2 bands Insiders have been net buyers of 5.4% shares of the company over the past six months. However, the stock is seeing signs of weakness, as it is currently trading below its 50-day and 200-day moving averages of $0.61 and $1.84, respectively. This article provides insight into the metrics that are reflective of the current challenges the company ... wildfire bcguardian life of america Processa Pharma (NASDAQ: PCSA) just reported results for the first quarter of 2024. Processa Pharma reported earnings per share of -$1.11. The company did not … felt electric PCSA. Press Releases Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering. 19d ago. PCSA. Company Announcements Processa Pharmaceuticals Announces Offering Pricing Details. 20d ago. 8K. PCSA. Company Announcements Processa Pharmaceuticals Secures $7M in Public Offering.Processa Pharmaceuticals Stock Forecast, PCSA stock price prediction. Price target in 14 days: 2.886 USD. The best long-term & short-term Processa ... thinking. fast and slowgordon parks artworksuika game' The Processa Pharmaceuticals stock forecast for tomorrow is $ 2.40, which would represent a 8.31% gain compared to the current price. In the next week, the price of PCSA is expected to increase by 11.71% and hit $ 2.48.. As far as the long-term Processa Pharmaceuticals stock forecast is concerned, here’s what our predictions are currently suggesting (these … houston texas to boston PCSA Candlestick Patterns Dozens of bullish and bearish live candlestick chart patterns for the Processa Pharmaceuticals Inc stock and use them to predict future market behavior. The Processa Pharmaceuticals stock patterns are available in a variety of time frames for both long and short term investments. unlock atpopit gamedc to nyc flight Processa Pharma (NASDAQ: PCSA) just reported results for the first quarter of 2024. Processa Pharma reported earnings per share of -$1.11. The company did not report any revenue for the quarter ...Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces Dr. David Young, President of Research and Development, will present at the MedInvest Oncology Investor Conference. Processa CEO George Ng will be available for one-on-one meetings with investors at the conference venue. ... N/A Ranked by Stock Gains. N/A Ranked by …